Respiratory Failure

🩺What is Respiratory Failure?

The Rapid Emergency Medicine Score (REMS) was developed by Olsson, Terent, and Lind at Uppsala University Hospital, Sweden, and published in the Journal of Internal Medicine in 2004. It was designed as a simplified, physiology-based severity score specifically for emergency department patients, requiring no laboratory data for calculation. The score uses six physiological variables: age, mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), peripheral oxygen saturation (SpO₂), and Glasgow Coma Scale (GCS). All six variables are routinely measured at ED triage or immediately upon patient arrival, allowing REMS to be calculated within minutes of presentation. The total score ranges from 0 to 26, with each variable scored from 0 to 4 (except age, which scores from 0 to 6). Higher scores correlate with increased in-hospital mortality. In the original validation study of 1,207 non-surgical ED patients, REMS demonstrated an area under the receiver operating characteristic curve (AUC) of 0.86 for predicting in-hospital mortality, comparable to APACHE II (AUC 0.87) despite requiring substantially fewer variables and no laboratory inputs. REMS was derived by modifying the APACHE II scoring system to rely exclusively on bedside-available parameters. Subsequent validation studies have confirmed its prognostic performance across diverse ED populations, including medical, surgical, trauma, and septic patients. The score has been translated into multiple clinical applications: identifying high-risk patients for ICU admission, predicting 30-day mortality, and stratifying patients in emergency medicine research. Its simplicity and speed make REMS particularly valuable in resource-limited settings where laboratory capabilities may be restricted or delayed. This calculator provides the full REMS assessment with categorized inputs for each of the six variables, following the original Olsson scoring system.

📊Clinical Assessment & Risk Scoring

Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Respiratory Failure:

• Rapid Emergency Medicine Score (REMS)

  The Rapid Emergency Medicine Score (REMS) is a simple, physiologic-based score for emergency department patients that predicts in-hospital mortality without requiring laboratory data.

• GOLD COPD Staging Calculator

  The GOLD COPD Staging system, developed by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is the internationally accepted standard for classifying COPD severity and guiding treatment decisions based on airflow limitation, symptom burden, and exacerbation history.

• Pediatric Early Warning Score (PEWS)

  The Pediatric Early Warning Score (PEWS) is a validated clinical scoring system designed to identify hospitalized children at risk of clinical deterioration. It is widely used in pediatric wards, emergency departments, and critical care settings globally.

🧬Diagnostic Logic & Scoring Breakdown

The REMS is calculated by summing points assigned in six independent physiological categories. Age points follow the same scale as APACHE II: less than 45 years scores 0, 45-54 scores 2, 55-64 scores 3, 65-74 scores 5, and 75 years or older scores 6. Mean arterial pressure (MAP) scoring: MAP 70-109 mmHg is normal (0 points); deviations in either direction earn points, with MAP below 50 mmHg or 160 mmHg or above scoring the maximum of 4 points. Heart rate scoring is symmetric for bradycardia and tachycardia: rates 70-109 bpm score 0; rates below 40 bpm or 180 bpm or above score 4 points. Respiratory rate scoring: normal rate 12-24 breaths per minute scores 0; extremes below 6 or 50 or above per minute score 4 points. Oxygen saturation is assessed using SpO₂ on room air or the initial supplemental oxygen level available: 95% or above scores 0 (normal), 90-94% scores 1, 85-89% scores 2, 75-84% scores 3, and below 75% scores 4 points. Glasgow Coma Scale scoring is simplified from APACHE II: GCS 15 scores 0, 13-14 scores 1, 10-12 scores 2, 6-9 scores 3, and less than 6 scores 4 points. Unlike APACHE II, REMS does not use the 15 minus GCS formula — each GCS range maps directly to a predefined score. The total REMS ranges from 0 to 26. Mortality risk stratification by REMS: a score of 0-6 predicts less than 5% in-hospital mortality (low risk); 7-13 predicts 5-25% mortality (moderate risk); and 14 or above predicts greater than 25% mortality (high risk). Each point increase in REMS correlates with an approximately 30% increase in the odds of in-hospital mortality. Because REMS uses only initial ED vital signs and GCS without laboratory data, it can be repeated serially to track clinical trajectory, though the original validation used a single calculation at ED presentation.

📢Clinical Significance & Implications

REMS fills an important gap in emergency medicine by providing a rapid, objective severity assessment that can be performed within minutes of ED arrival, without requiring any laboratory investigations. This makes it particularly valuable in several clinical scenarios: early triage decisions, where REMS can identify high-risk patients who may benefit from immediate ICU admission or critical care consultation; resource-limited settings, where laboratory capabilities may be delayed or unavailable; mass casualty incidents, where rapid physiologic scoring helps prioritize patients; and situations requiring serial assessment, where REMS can be recalculated easily to track clinical deterioration or improvement. The score has been validated across multiple clinical populations in the ED setting. In medical patients, REMS predicts in-hospital mortality with good discrimination (AUC 0.83-0.88 across studies). In trauma populations, REMS performs equivalently to the Revised Trauma Score (RTS) for predicting mortality. In sepsis, REMS correlates with disease severity and can identify patients at high risk of deterioration. A significant advantage of REMS is its strong correlation with APACHE II, despite using no laboratory data — the original Olsson study found an R² of 0.84 between REMS and APACHE II scores. This means REMS captures most of the prognostic information of APACHE II using only bedside parameters. However, REMS has limitations: the score was derived from non-surgical ED patients, and its performance in specific surgical subpopulations may differ; it does not account for chronic health conditions or immunocompromise, which may underestimate risk in certain patients; and it provides a single-point mortality prediction rather than tracking organ dysfunction over time (for which SOFA is better suited). Despite these limitations, REMS has gained widespread acceptance as a practical, rapid, and validated severity assessment tool for the ED, supporting triage decisions, clinical communication, and research stratification.

💡 Clinical Assessment Scenario Example

A 60-year-old male patient presents to the emergency department with community-acquired pneumonia and worsening dyspnea over three days. His initial vital signs at ED triage are: blood pressure 100/50 mmHg (calculated MAP = 65 mmHg), heart rate 115 bpm, respiratory rate 28 breaths per minute, and SpO₂ 88% on room air. His GCS is 15 (alert and oriented). The REMS scoring is calculated as follows: Age 60 falls in the 55-64 years category, scoring 3 points. MAP 65 mmHg falls in the 50-69 range, scoring 2 points. Heart rate 115 bpm falls in the 110-139 range, scoring 2 points. Respiratory rate 28/min falls in the 25-34 range, scoring 1 point. SpO₂ 88% falls in the 85-89% range, scoring 2 points. GCS 15 is normal, scoring 0 points. The total REMS score is 3 + 2 + 2 + 1 + 2 + 0 = 10. This places the patient in the moderate risk category (REMS 7-13), corresponding to an estimated in-hospital mortality of 5-25%. The patient is admitted for intravenous antibiotics, supplemental oxygen, and close monitoring. After 24 hours of treatment, repeat vital signs show improvement: MAP improves to 75 mmHg, heart rate decreases to 95 bpm, respiratory rate reduces to 20/min, and SpO₂ improves to 95% on 2 L/min nasal cannula, giving a recalculated REMS of 3 + 0 + 0 + 0 + 0 + 0 = 3, indicating clinical improvement and a low risk trajectory.

💊Common Medications & Interventions

The following pharmacological therapies and substances are commonly referenced or adjusted based on the clinical assessment of Respiratory Failure:

🔗Related Diseases & Conditions

These conditions are clinically associated with Respiratory Failure through shared risk-scoring calculators and assessment tools:

• Sepsis
• Chronic Obstructive Pulmonary Disease
• Emphysema
• Chronic Bronchitis
• Clinical Deterioration (Pediatric)
• Pediatric Sepsis
• Shock (Pediatric)

⚠️Clinical Assessment Pitfalls

• ❌ Mistake: Using REMS after treatment has started

  ✅ Correction: Calculate REMS using initial ED presentation vitals, before any interventions. Early treatment can improve vitals and falsely lower the score, underestimating true severity.

• ❌ Mistake: Substituting REMS for comprehensive assessment

  ✅ Correction: REMS is a screening tool. It does not replace full clinical assessment, diagnostic workup, or other severity scores like SOFA for ICU patients.

• ❌ Mistake: Using SpO₂ after supplemental oxygen without notation

  ✅ Correction: Document whether SpO₂ was measured on room air or with supplemental oxygen. If on oxygen, note the FiO₂ or flow rate. REMS was validated using initial SpO₂ in the ED, typically on room air.

• ❌ Mistake: Applying REMS in surgical or trauma patients without validation awareness

  ✅ Correction: REMS was originally validated in non-surgical ED patients. While subsequent studies have shown reasonable performance in trauma and surgical populations, the score may not capture surgical-specific risk factors.

• ❌ Mistake: Adding extra points for low GCS incorrectly

  ✅ Correction: Unlike APACHE II, REMS does not use the 15 minus GCS formula. Instead, GCS ranges map directly to points: GCS 15 = 0, 13-14 = 1, 10-12 = 2, 6-9 = 3, <6 = 4. Do not subtract from 15.

• ❌ Mistake: Using pre-bronchodilator FEV₁ instead of post-bronchodilator values

  ✅ Correction: GOLD staging requires post-bronchodilator spirometry. Pre-bronchodilator values may overestimate severity by not accounting for reversible airway obstruction.

• ❌ Mistake: Using FEV₁ alone for treatment decisions without ABE assessment

  ✅ Correction: GOLD 2024 emphasizes that treatment decisions must be based on the combined ABE assessment (exacerbation history + symptoms), not spirometric grade alone. Two patients with the same FEV₁ may require different treatments depending on group classification.

• ❌ Mistake: Using the old ABCD classification instead of the updated ABE system

  ✅ Correction: The GOLD 2023 revision consolidated groups C and D into Group E, recognizing that exacerbation risk, regardless of symptom burden, is the key driver of triple therapy indication. Use the new ABE classification.

• ❌ Mistake: Classifying 2 moderate exacerbations as Group B instead of Group E

  ✅ Correction: Any patient with ≥2 moderate exacerbations or ≥1 exacerbation hospitalization in the past year automatically belongs to Group E, regardless of mMRC or CAT score. This triggers the recommendation for triple therapy (ICS/LABA/LAMA).

• ❌ Mistake: Using CAT and mMRC inconsistently for symptom assessment

  ✅ Correction: Both CAT and mMRC are validated for symptom assessment, but they are not interchangeable. If CAT ≥10 indicates high symptoms, choose CAT. If mMRC ≥2 indicates high symptoms, choose mMRC. Do not average or combine the two.

• ❌ Mistake: Delaying escalation while waiting for the "next scheduled" PEWS assessment when the child's clinical status has clearly deteriorated

  ✅ Correction: PEWS is a structured tool to support clinical judgment, not replace it. If the child appears clinically worse despite a stable PEWS score, escalate immediately based on clinical concern. Always document the reason for escalation separately from the score.

• ❌ Mistake: Recording the worst-ever PEWS score rather than the current score during the assessment period

  ✅ Correction: PEWS should reflect the child's status at the time of assessment. Document the current scores in each domain based on the examination findings at that moment. Trends over time are clinically important — serial scores showing an upward trend even within the same risk band warrant attention.

🚑When to Seek Medical Attention

This reference supports clinical assessment of Respiratory Failure; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.

❓Frequently Asked Questions

📚Evidence-Based References